Table 3 Summary of local tumor control and 1-year mortality in the unmatched and matched cohort in all patients and stratified in BCLC B and C

All patients

n = 367

n = 35

n = 70

n = 35

Target lesions

367

46

70

46

Local tumor control^b

n (%) [95%CI]

273 (74.4)

[70.0–79.0]^a

39 (84.8)

[71.9–96.9]

58 (82.9)

[74.3–91.4]

39 (84.8)

[71.9–96.9]

1-year-mortality

n (%) [95%CI]

141 (38.4)

[33.8–43.6]

17 (53.1)

[37.5–71.9]

37 (52.9)

[40.0–64.3]

17 (53.1)

[37.5–68.8]

BCLC B

n = 29

n = 24

n = 49

n = 24

Target lesions

299

23

49

23

Local tumor control

n (%) [95%CI]

225 (75.3)

[70.6–80.2]

19 (82.6)

[66.7–95.8]

41 (83.7)

[72.3–93.5]

19 (82.6)

[66.7–95.8]

1-year-mortality

n (%) [95%CI]

100 (33.4)

[28.1–39.1]

11 [45.8)

[30.0–71.4]

20 (40.8)

[26.9–55.0]

11 (45.8)

[29.2–70.8]

BCLC C

n = 68

n = 11

n = 21

n = 11

Target lesions

68

23

21

23

Local tumor control

n (%) [95%CI]

48 (70.6)

[60.0–81.0]

20 (87.0)

[72.2–100]

17 (81.0)

[64.0–95.8]

20 (87.0)

[72.2–100]

1-year-mortality

n (%) [95%CI]

41 (60.3)

[48.3–70.9]

6 (5.4)

[27.3–90.0]

17 (81.0)

[64.0–95.8]

6 (5.4)

[27.3–90.0]